Fund details
Series |
Currency |
Fund code |
MER * (%) |
|---|---|---|---|
| F | CAD | 35075 | 0.99% |
To provide long-term capital growth by investing in equity securities of European companies in order to provide exposure to growth opportunities in the European economy and diversification benefits beyond North America.
Series |
Currency |
Fund code |
MER * (%) |
|---|---|---|---|
| F | CAD | 35075 | 0.99% |
Top 10 Holdings |
% Assets |
|---|---|
| ASML Holding NV | 4.7% |
| AstraZeneca PLC | 3.4% |
| Novartis AG | 3.3% |
| Roche Holding AG | 3.0% |
| HSBC Holdings PLC | 2.5% |
| Iberdrola SA | 2.2% |
| Schneider Electric SE | 2.0% |
| Siemens AG | 1.9% |
| Allianz SE | 1.9% |
| Nestle SA | 1.7% |
| Total % of Top 10 Holdings | 26.6% |
| 1 Mth | 3 Mth | 6 Mth | 1 year | 3 years | 5 years | 10 years | Since Inception | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 2.2 | 7.2 | 13.2 | 16.7 | 14.0 | 9.7 | 8.2 | 5.4 | Fund |
| YTD* | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total distributions | 0.00 | 3.71 | 1.12 | 1.00 | 0.46 | 1.62 | 0.41 | 0.48 | 1.09 | 1.20 | 0.59 |
| Interest | --- | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | --- | --- |
| Canadian dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Foreign dividends | --- | 0.45 | 0.56 | 0.59 | 0.43 | 0.34 | 0.30 | 0.51 | 0.55 | 0.39 | 0.34 |
| Foreign taxes paid | --- | -0.04 | -0.07 | -0.06 | -0.04 | -0.03 | -0.03 | -0.04 | -0.06 | -0.04 | -0.03 |
| Capital gains | --- | 3.30 | 0.63 | 0.46 | 0.06 | 1.30 | 0.14 | --- | 0.60 | 0.85 | 0.28 |
| Return of capital | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.